Generative AI isn’t going away, that’s for sure. But that doesn’t mean we have to live with the most dangerous and problematic aspects of gen-AI. Here’s four things that need to happen for generative ...
Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...
A number of neurodegenerative diseases of the brain are characterized by inclusions within neurons that are comprised of aggregated fibrils of hyperphosphorylated tau protein. These disorders, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results